| WPW Syndrome | Wolff-Parkinson-White Syndrome ? CIx 1. Drugs; AV Conduct... |
|---|---|
| BL | Barre-Lieou [syndrome]; basal lamina; baseline; Bessey-Lowry [unit]; black light; bladder; bleeding;... |
| BLE | both lower extremities; buffered lidocaine with epinephrine |
| LANE | lidocaine, atropine, naloxone, epinephrine [drugs that may be administered via endotracheal tube] |
| LBC | lidocaine blood concentration; lymphadenosis benigna cutis |
| antibiotic resistance | The ability of a bacterium tosynthesise a protein that neutralises an antibiotic. (09 Oct 1997) |
|---|---|
| antibiotic resistance gene | Genes in a microorganism which confer resistance to antibiotics, for example by coding for enzymes which destroy it, by coding for surface proteins which prevent it from entering the microorganism, or by being a mutant form of the antibiotic's target so that it can ignore it. (09 Oct 1997) |
| antibiotic-resistant | Indicating microorganisms that continue to multiply although exposed to antibiotic agents. (05 Mar 2000) |
| antibiotic sensitivity | Microbial susceptibility to antibiotics. See: antibiotic sensitivity test, minimal inhibitory concentration. (05 Mar 2000) |
| antibiotic sensitivity test | The in vitro testing of bacterial cultures with antibiotics to determine susceptibility of bacteria to antibiotic therapy. (05 Mar 2000) |
| broad spectrum antibiotic | An antibiotic having a wide range of activity against both Gram-positive and Gram-negative organisms. (05 Mar 2000) |
| resistance, antibiotic | The ability of bacteria and other microorganisms to withstand an antibiotic to which they were once sensitive (and were once stalled or killed outright). Also called drug resistance. (12 Dec 1998) |
| peptide antibiotic lactonase | <enzyme> Peptide lactone and water gives linear peptide Registry number: EC 3.1.1.- (26 Jun 1999) |
| diarrhoea, antibiotic-induced | A bacterium called Clostridium difficile (C.difficile), one of the most common causes of infection of the large bowel (colon). Patients taking antibiotics are at particular risk of becoming infected with C. Difficile. Antibiotics disrupt the normal bacteria of the bowel, allowing C. Difficile bacteria (and other bacteria) to become established and overgrow the colon. Many persons infected with C. Difficile bacteria have no symptoms but can become carriers of the bacteria and infect others. In other people, a toxin produced by C. Difficile causes diarrhoea, abdominal pain, severe inflammation of the colon (colitis), fever, an elevated white blood count, vomiting and dehydration. In severely affected patients, the inner lining of the colon becomes severely inflamed (a condition called pseudomembranous colitis). Rarely, the walls of the colon wear away and holes develop (colon perforation), which can lead to a life-threatening infection of the abdomen. (12 Dec 1998) |
| transport antibiotic | A substance that makes biomembranes permeable to certain ions. (05 Mar 2000) |
| Bielschowsky, Max | <person> German neuropathologist, 1869-1940. See: Bielschowsky's disease, Bielschowsky's stain, Jansky-Bielschowsky disease. (05 Mar 2000) |
| Bockhart, Max | <person> German physician, 1883-1921. See: Bockhart's impetigo. (05 Mar 2000) |
| Burger, Max | <person> German physician, *1885. See: Burger-Grutz syndrome, Burger-Grutz disease. (05 Mar 2000) |
| Madlener, Max | <person> German surgeon, 1868-1951. See: Madlener operation. (05 Mar 2000) |
| Max | Transcription factor: forms homodimers which then interact with CACGTG motif of DNA repressively, but will form heterodimers with Myc that bind the same motif with greater affinity and activate the downstream gene. (18 Nov 1997) |